{
    "nctId": "NCT00182520",
    "officialTitle": "A Study of Topiramate Augmentation in Serotonin Reuptake Inhibitor (SRI) -Refractory Obsessive Compulsive Disorder",
    "inclusionCriteria": "* Outpatient with primary DSM- IV OCD\n* Completion of a 14-week open label trial of one the following SRI's: fluoxetine 80 mg/day, paroxetine 60 mg/day, fluvoxamine 300 mg/day, clomipramine 250 mg/day, sertraline 200 mg/day, citalopram 60 mg/day, escitalopram 30 mg/day and demonstrating a non or partial responses to SRI treatment (CGI-I of 3 or 4, Y-BOCS reduction of \\< 35%)\n* Stable (8 wks or longer) concurrent medications including benzodiazepines, sedative hypnotics, antipsychotics, and antidepressants.\n* Must have minimum age of 18 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "* Any other primary DSM-IV diagnosis; DSM-IV criteria for body dysmorphic disorder, bipolar affective disorder, schizophrenia, psychotic disorder, current alcohol/substance abuse.\n* A previous adequate trial of topiramate\n* Comorbid major depressive disorder diagnosis which predates OCD diagnosis\n* Cognitive behavioural therapy or additional psychotherapy in past four months\n* Allergy or hypersensitivity to topiramate\n* BMI \\< 20\n* History of kidney stones"
}